Beck Mack & Oliver’s Allergan Inc AGN Stock Holding History

Beck Mack & Oliver’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-2,500	Closed	-$531K	–	381
2014 Q4	$531K	Hold	2,500	–	–	0.01%	233
2014 Q3	$445K	Sell	2,500 -900	-26%	-$149K	0.01%	252
2014 Q2	$575K	Sell	3,400 -698	-17%	-$109K	0.01%	236
2014 Q1	$509K	Sell	4,098 -1,600	-28%	-$195K	0.01%	231
2013 Q4	$633K	Buy	5,698 +1,498	+36%	+$143K	0.02%	225
2013 Q3	$380K	Hold	4,200	–	–	0.01%	252
2013 Q2	$354K	Buy	+4,200	New	+$436K	0.01%	255

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Beck Mack & Oliver's AGN Position: Q1 2015 in Review

Beck Mack & Oliver sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,500 shares — an estimated $531K sold.

Beck Mack & Oliver first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $633K in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Beck Mack & Oliver reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Beck Mack & Oliver sold 2,500 Allergan Inc shares in Q1 2015, an estimated $531K.
Beck Mack & Oliver first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Beck Mack & Oliver's Allergan Inc position peaked at $633K in Q4 2013.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Beck Mack & Oliver's 13F filing for Q1 2015, filed 28 Apr 2015.